Abstract:AIM:To evaluate the expression of fragile histidine triad (FHIT) gene protein, product of a candidate tumor suppressor, and to investigate the relationship between FHIT, cell apoptosis and proliferation, and pathological features of primary hepatocellular carcinoma (HCC). METHODS:Forty-seven HCC and ten normal liver specimens were collected during surgical operation between 2001 and 2003.FHIT and proliferating cell nuclear antigen (PCNA) expression were detected by immunohistochemistry, and apoptotic level was evaluated by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay on the tissue sections. RESULTS:All normal liver tissues showed a strong expression of FHIT, whereas 28 of 47 (59.6%) carcinomas showed a significant loss or absence of FHIT expression (P = 0.001).The proportion of reduced FHIT expression in those carcinomas at stages III-IV (70.6%) and in those with extrahepatic metastasis (86.7%) showed an increasing trend compared with those at stages I-II (30.8%,P = 0.013) and those without metastasis (46.9%,P = 0.010) respectively.Apoptotic incidence in advanced TNM stage carcinoma and those with positive FHIT expression was higher than that in early stage carcinoma (P = 0.030) and in those with negative FHIT expression (P = 0.044) respectively.The proliferating potential of hepatocellular carcinoma was associated with FHIT expression (P = 0.016) and the aggressive feature (P = 0.019).Kaplan-Meier analysis demonstrated that the survival time of these 47 patients correlated with TNM stage, FHIT expression and metastasis. CONCLUSION:There is marked loss or absence of FHIT expression, as well as abnormal apoptosis-proliferation balance in HCC.FHIT may play an important role in carcinogenesis and development of HCC.

The Expression of Fragile Histidine Triad Protein in Endometrial Carcinomas

Expression of FHIT Protein,ki-67 and Their Significance in Endometrial Carcinoma

Expressions of FHIT in Cervical Cancer and Cervical Intraepithelial Neoplasia

[Relationship Between the Expression of Fragile Histidine (FHIT) and the Development of Vulvar Carcinoma].

The Expression of FHIT Protein in Progression of Breast Carcinoma

Fragile Histidine Triad Expression and Its Clinical Significance in Gastric Cancer

Clinicopathological Significance of Expression of Fragile Histidine Triad Protein in Neuroendocrine Lung Carcinoma

Upregulation of FHIT Gene Expression in Endometrial Carcinoma by RNA Activation.

Fragile histidine triad expression in vulvar cancer and vulvar condyloma acuminatum

Expression of Fragile Histidine Triad in Primary Hepatocellular Carcinoma and Its Relation with Cell Proliferation and Apoptosis

Clinicopathological Significance of Fragile Histidine Triad Transcription Protein Expression in Breast Carcinoma.

Study on Fragile Histidine Triad Protein Expression in Human Sporadic Colorectal Carcinoma

Expression of FHIT Protein in Primary Carcinoma of the Gallbladder and Its Significance.

[Relationship between the reduction of FHIT expression and the development of cervical carcinoma].

Study on the microsatellite instability and protein expression of FHIT gene in breast cancer

Study on the relationship of FHIT,HPV16E6,HPV16E7 protein expression in cervical carcinoma and in cervical intraepithelial neoplasia

[Expression and Significance of Fragile Histidine Triad in Oral Cancer and Precancerous Lesions].

The expressions of HSFl and XAF1 in endometrial carcinoma and their correlation analysis

Expression of Fragile Histidine Triad Protein in Lung Cancer Tissues and Its Correlation with Multidrug Resistance Protein 1

[The Relationship Between Expression of Fhit and Biological Behaviors of Hypopharyngeal Carcinoma].

Exploration of the Correlation Between FHIT Gene and Cervical Carcinoma